| CAT No: | CL-TMDS-29 |
| CAS No: | NA |
| Mol.F: | C813C6H7Cl2NO3 |
| Mol.Wt.: | 314.1 |
| Rel. Cas No: | |
| Chemical Name: | 2-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic-3a,4,5,6,7,7a-13C6 acid |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Tafamidis 13C6 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Tafamidis 13C6 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic-3a,4,5,6,7,7a-13C6 acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Tafamidis Molecular Formula: C813C6H7Cl2NO3
Molecular Weight: 314.1
Storage: Store in a cool, dry place.
| Product Name: | Tafamidis 13C6 |
| CAS No: | NA |
| Mol.F.: | C813C6H7Cl2NO3 |
| Mol.Wt.: | 314.1 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: